Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule

The standard first-line treatment in recurrent/metastatic head and neck squamous cell carcinoma combines Cisplatin, 5 Fluorouracil and Cetuximab, but many patients aren’t eligible. We retrospectively evaluated the efficacy and the tolerability of Carboplatin and Paclitaxel in this indication, mostly...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Pêtre, Adeline, Dalban, Cécile, Karabajakian, Andy, Neidhardt, Eve-Marie, Roux, Pierre Eric, Poupart, Marc, Deneuve, Sophie, Zrounba, Philippe, Fayette, Jérome
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2018
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955142/
https://ncbi.nlm.nih.gov/pubmed/29774120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25157
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items